ClinicalTrials HQ

Study of ACR-2316 in Specific Advanced Solid Tumors

Study of ACR-2316 in Specific Advanced Solid Tumors

Recruiting · NCT06667141 · Registry updated 2026-09-23
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of ACR-2316 in Specific Advanced Solid TumorsCongenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, central nervous system malformation, hereditary disease, hereditary sensory and autonomic neuropathy, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathyRecruitingPhase 1 / Phase 22026-09-23NCT06667141

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Acrivon Therapeutics3

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beth Israel Deaconess Medical CenterBostonUnited States462
Carolina BioOncology InstituteHuntersvilleUnited States22
Denver Health OneDenverUnited States1
Florida Cancer SpecialistSarasotaUnited States2
Hoag Memorial Hospital PresbyterianNewport BeachUnited States66
HonorHealth Research InstitutePhoenixUnited States1
Montefiore Medical CentreThe BronxUnited States1
NEXT OncologySan AntonioUnited States70
NEXT VirginiaFairfaxUnited States83
Precision NextGen Oncology & Research CenterBeverly HillsUnited States6
Rhode Island HospitalProvidenceUnited States229
Roswell Park Comprehensive Cancer CenterBuffaloUnited States32
Tennessee OncologyFranklinUnited States1
The University of Texas MD Anderson Cancer CenterHoustonUnited States1
University of MichiganAnn ArborUnited States538